课题基金 / 基金详情

Enhancing Recruitment and Retention of Underrepresented Pregnant Hispanic Women in a Phase III Randomized Clinical Trial

Enhancing Recruitment and Retention of Underrepresented Pregnant Hispanic Women in a Phase III Randomized Clinical Trial
在 III 期随机临床试验中加强对代表性不足的西班牙裔孕妇的招募和保留
批准号:
9446350
负责人:
SUSAN E CARLSON
金额:
$11.37万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-01-19 至 2020-12-31

项目摘要

项目成果

SUSAN E CARLSON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The current proposal does not change the original scope, aims or research design of our ongoing RCT (R01 HD083292; ClinicalTrials.gov ID: NCT02626299) which seeks to determine whether high versus low DHA intake during pregnancy can successfully reduce early preterm birth. Instead this proposal directs additional resources to evaluate community based participatory research strategies for the recruitment and retention of underrepresented minorities, specifically pregnant Hispanic women. We seek to 1) identify barriers pregnant Hispanic women face when accessing clinical care, 2) identify their perception of clinical research participation as it relates to the health of their pregnancy and unborn child and 3) increase enrollment and retention of Hispanic women in our clinical trial to achieve a nationally representative sampling. A newly formed interdisciplinary collaboration with a multilingual, culturally appropriate center with a successful track record of Hispanic community engagement will guide our efforts. Outcome data will include the number of Hispanic participants who enroll into and complete our clinical trial as well as descriptive methods to improve commitment of underrepresented minorities for future studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Docosahexaenoic Acid (DHA) Supplementation in Pregnancy to Reduce Early Preterm Birth
Docosahexaenoic Acid (DHA) Supplementation in Pregnancy to Reduce Early Preterm Birth
DHA Supplementation and Pregnancy Outcome
DHA Supplementation and Pregnancy Outcome
海外基金